National Lung Cancer Screening Programme

Jim Shannon Excerpts

Thursday 25th June 2026 Westminster Hall

[Jim Shannon (Strangford) (DUP)]

It is a pleasure to serve under your chairship, Sir Alec. We will be together all afternoon if you are here for the next debate as well. I welcome this debate on the national lung cancer screening programme. I thank the hon. Member for Wokingham (Clive Jones) for securing it, and for his dedication to anything to do with cancer. The hon. Gentleman has made a name for himself in this House for putting forward these topics. I thank him for his knowledge and for his interest.

The lung cancer screening programme was set up to find lung cancer early, before symptoms appear, especially in people with a history of smoking, who are the group with the highest risk. The UK’s biggest ever early diagnosis initiative for lung cancer, the programme is delivered through targeted lung health checks. The hon. Gentleman referred to how the scheme delivers checks. They take place in local hospitals and in the community, and in vans in settings such as supermarket car parks, so nobody can say they have not had the opportunity to have the check done.

The checks are designed to target those aged 55 to 74 who are current or former smokers, as identified from their GP records, who are registered with a GP and who live in an area where the programme has been rolled out. I understand that the programme is expanding rapidly, region by region and is expected to be fully rolled out across England by 2030. That is welcome. Indeed it is, I would say, almost there.

We do not know how many people have attended the checks, but the United Kingdom National Screening Committee noted that more than 1.9 million have been invited to the programme, which is operating across 25% of England. NHS England has stated that, to date, some 5,037 lung cancers have been detected early since 2019; 76% of those were found at stage 1 or 2. Early-stage diagnosis improves five-year survival nearly twentyfold compared with late-stage diagnosis, so again that is a success of the programme.

The screening programme has been an outstanding success, and I commend the Minister and all those involved in the Department and NHS England on such an extraordinary achievement—they deserve every accolade for it. It has fitted perfectly with the 10-year health plan. We should give credit to the Minister and the Government for the plan and for all they have done to improve health; there are many things they can point to as being successful. It is also nice to see the shadow Minister, the hon. Member for Hinckley and Bosworth (Dr Evans), in his place; it would not be a health debate if he and I were not here together—and here we are again.

As chair of the all-party parliamentary group for respiratory health, I warmly welcome the three shifts arising from the 10-year health plan. The screening programme is an excellent example of how well they have worked in practice. The first shift was from analogue to digital: most of the reminders for eligible patients are by text message—that is the new way of doing it; I may not be entirely geared into it, but I understand the process. The second shift was from hospital to community: running the tests in mobile units means they are less intimidating and closer to home. In fact, around 70% of initial screening was delivered via mobile units, improving access in deprived areas where smoking rates are highest. If we want to address the issue, we must go to the coal quay, as we would say, and meet and speak to the people.

The third shift was from treatment to prevention. Early-stage detection dramatically improves survival. The lung checks programme has crucially identified over 100,000 incidental findings of emphysema, one of the key conditions of COPD. However, those incidental findings are not generally followed up, nor do they lead to referrals for further investigation or treatment. Will the Minister ask his Department to consider a follow-up? If incidental findings are identified and there is a chance of curing or addressing the issue, that is the time to strike. The men’s health strategy called for better incidental outcomes, and it contains the ambition of

“ensuring incidental findings from the NHS Lung Cancer Screening programme, including respiratory illnesses such as COPD, are followed up according to the NHS Lung Cancer Screening programme incidental findings protocol and relevant NICE guidance”.

Can the Minister update us on how that is progressing within the men’s health strategy?

We have discussed the outstanding FRONTIER Hull trial with Professor Mike Crooks from Hull, who is piloting an integrated pathway that links screening findings to respiratory assessment and treatment in partnership with the NHS. I commend the work he is undertaking. So far, 383 of the 819 people—47%—recalled to the clinic have received a new diagnosis of COPD and started treatment through a streamlined one-stop clinic, meaning that those patients could begin treatment immediately rather than waiting while their symptoms progressed and their condition deteriorated.

I underline again that it has been shown that a one-stop diagnostic clinic is feasible, can be achieved and fits well with the three shifts. The approach can be tailored to meet local needs, helping integrated care systems to reduce hospital demand and improve patient outcomes. It has been estimated by Chiesi that integrating COPD case finding into lung cancer screening could save the NHS some £33 million over 10 years. That saving cannot be ignored, especially at a time when every pound counts. If it is possible to save some £33 million, it should be in part because of the screening programme.

I urge the Minister to look closely at the outcomes of the trial. This topic deserves a full debate; but more than that, it deserves an outcome. Screening saves lives, ultimately saves money and, importantly, saves needless heartbreak and pain. Let us invest in ourselves and in the process that we are discussing today.

--- Later in debate ---

[The Minister for Care (Stephen Kinnock)]

It is a real pleasure to serve under your chairmanship, Sir Alec. I congratulate the hon. Member for Wokingham (Clive Jones) on securing this important debate and on his continued and relentless advocacy for people affected by lung cancer. I am grateful to the hon. Member for Strangford (Jim Shannon); to the Liberal Democrat spokesman, the hon. Member for Didcot and Wantage (Olly Glover); and to the shadow Minister, the hon. Member for Hinckley and Bosworth (Dr Evans), for their comprehensive and constructive contributions. I pay tribute to my hon. Friend the Member for Washington and Gateshead South (Mrs Hodgson), the lead Minister on this policy area.

There is a great deal of consensus across the House on this issue. We all want to see more lung cancers diagnosed earlier, more lives saved and fewer families affected by the devastating consequences of a late diagnosis. Lung cancer remains one of the greatest cancer challenges that we face. More than 42,000 people were diagnosed with lung cancer in England in 2023, and about 35,000 people lose their life to the disease across the United Kingdom each year.

Lung cancer is also one of the cancers most strongly associated with deprivation. People living in the most deprived communities experience higher rates of smoking, a higher incidence of lung cancer and poorer health outcomes. That is why tackling lung cancer is about not only improving cancer survival, but reducing some of the most persistent health inequalities in our society. For too long, outcomes for lung cancer have lagged behind those for many other cancers. The reason for that is well understood: too many people are diagnosed when their cancer is already at an advanced stage, limiting treatment options and reducing the likelihood of successful outcomes.

That is why early diagnosis is absolutely critical. When lung cancer is diagnosed at stage 1, five-year survival is over 60%. By stage 4, it falls to just over 4%. Those figures alone demonstrate why finding lung cancer earlier remains one of the most effective ways of improving survival. The Government fully recognise the importance of this challenge. Improving outcomes for lung cancer and other less survivable cancers will be critical to achieving the Government’s ambitious objective that 75% of people diagnosed with cancer should survive for at least five years. That is why the national cancer plan places a strong focus on earlier diagnosis, reducing inequalities and ensuring that people with less survivable cancers receive the attention and support that they deserve.

[Jim Shannon]

This debate is about lung cancer, but I noticed a story in the paper today about an increase of between 5% and 10% in the number of people who now have breast cancer. Does the Minister agree that that underlines the issue that while there are many advances in cancer, and we welcome all of them, there is still a long way to go?

[Stephen Kinnock]

The hon. Gentleman is absolutely right. There is a lot more work to be done, and it is a priority for the Government: it is right up there in the 10-year plan and the priorities. As he said in his excellent speech, we need to mobilise every one of the shifts—from analogue to digital, from hospital to community and from sickness to prevention—in the battle against cancer, because it is a formidable enemy and we need every single weapon we can deploy to defeat it.

We are determined to break the historical pattern of slow progress and finally give people with less survivable cancers the focus, urgency and outcomes that they deserve. That commitment is already being translated into action through the NHS lung cancer screening programme. The programme is designed to identify cancers at an earlier stage among those at highest risk, particularly people aged 55 to 74 with a history of smoking. Smoking remains responsible for about 72% of lung cancers, which is why a targeted approach is both clinically effective and evidence-based.

The results so far have been extremely encouraging: more than 1.8 million people have attended a lung health check through the programme, and more than 11,000 people have been diagnosed with lung cancer. Most importantly, 77% of cancers detected through the programme have been diagnosed at stage 1 or stage 2; outside the programme, the equivalent figure is about 30%. That means that thousands of people are receiving a diagnosis earlier, accessing treatment sooner and benefiting from significantly improved prospects for survival.

The programme is already demonstrating how earlier diagnosis can transform outcomes. Recent NHS England data shows a significant improvement in early-stage diagnosis in areas participating in the programme. That means more people are being diagnosed when treatment is most effective and when there is the greatest opportunity for curative intervention.

The hon. Member for Wokingham and others have spoken about the importance of a truly national programme. I agree that every eligible person should have the opportunity to benefit from lung cancer screening. That is why the Government are committing more than £650 million to complete the roll-out of lung cancer screening across England by 2030. Through the national cancer plan, we have committed to ensuring that every eligible person in England receives their first invitation for a check by 2030, helping thousands more people to benefit from earlier diagnosis and improved outcomes.

This investment reflects the Government’s confidence in the programme and the evidence supporting it. By 2035, lung cancer screening is expected to diagnose up to 50,000 cancers and identify at least 23,000 cancers at an earlier stage, helping thousands more people to receive potentially lifesaving treatment. This represents one of the most ambitious cancer screening programmes anywhere in the world.